These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28856795)

  • 21. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
    Chai J; Ho PC
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):291-4. PubMed ID: 24135383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
    Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
    Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial.
    Creinin MD; Schwartz JL; Pymar HC; Fink W
    BJOG; 2001 May; 108(5):469-73. PubMed ID: 11368131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy termination.
    Bygdeman M; Gemzell Danielsson K; Marions L; Swahn M
    Steroids; 2000; 65(10-11):801-5. PubMed ID: 11108891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different dosing intervals of mifepristone-misoprostol for second-trimester termination of pregnancy: A meta-analysis and systematic review.
    Wu L; Xiong W; Zeng M; Yan A; Song L; Chen M; Wei T; Zu Q; Zhang J
    Int J Gynaecol Obstet; 2021 Aug; 154(2):195-203. PubMed ID: 33332580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of mifepristone - Prostaglandin analogue combination in medical termination of pregnancy up to and beyond 7 weeks of amenorrhea: The RYMMa study.
    Agostini A; Zinovieva E; Quaranta LM; Herman-Demars H; Frantz S; Sicot M;
    Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():95-101. PubMed ID: 32947143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
    Dickinson JE; Brownell P; McGinnis K; Nathan EA
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy.
    Jain JK; Dutton C; Harwood B; Meckstroth KR; Mishell DR
    Hum Reprod; 2002 Jun; 17(6):1477-82. PubMed ID: 12042265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical methods of early abortion in developing countries. Consensus statement. The Population Council.
    Contraception; 1998 Nov; 58(5):257-9. PubMed ID: 9883380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandins for first-trimester termination.
    Meckstroth KR; Darney PD
    Best Pract Res Clin Obstet Gynaecol; 2003 Oct; 17(5):745-63. PubMed ID: 12972012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol.
    Bracken H; Clark W; Lichtenberg ES; Schweikert SM; Tanenhaus J; Barajas A; Alpert L; Winikoff B
    BJOG; 2011 Jan; 118(1):17-23. PubMed ID: 21091926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of medical abortion using mifepristone in combination with a prostaglandin analogue.
    Fiala C; Gemzel-Danielsson K
    Contraception; 2006 Jul; 74(1):66-86. PubMed ID: 16781264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue.
    Maria B; Stampf F; Goepp A; Dubois C
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):35-40. PubMed ID: 2376278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.